AdaptHealth (AHCO)
(Delayed Data from NSDQ)
$9.08 USD
+0.42 (4.85%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $9.08 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AHCO 9.08 +0.42(4.85%)
Will AHCO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AHCO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AHCO
AdaptHealth Corp. (AHCO) Beats Q2 Earnings and Revenue Estimates
Myriad Genetics (MYGN) Expands in MRD Testing With New Collab
AHCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Implied Volatility Surging for AdaptHealth (AHCO) Stock Options
AHCO or PBH: Which Is the Better Value Stock Right Now?
Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
Other News for AHCO
AdaptHealth (AHCO) Receives a Buy from Truist Financial
Buy Rating Affirmed for AdaptHealth on Strong Q2 Performance and Strategic Growth Initiatives
AdaptHealth Analysis: Hold Rating Amidst Revised Guidance and Financial Headwinds
AHCO Stock Earnings: AdaptHealth Beats EPS, Beats Revenue for Q2 2024
Palantir, Uber report Q2 beats: Morning Buzz